Skip to content

Comparison of the effect of hyaluronic acid injection versus extracorporeal shockwave therapy on chronic plantar fasciitis: a randomized controlled trial

Comparison of the effect of hyaluronic acid injection versus extracorporeal shockwave therapy on chronic plantar fasciitis: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-97vkx4
Enrollment
Unknown
Registered
2020-07-22
Start date
2020-10-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fasciitis Plantar

Interventions

We will recruit a total of 80 patients. After that, such patients will be randomized to the infiltration group with hyaluronic acid or to the shock wave therapy group. The treatments will be carried o
Drug
Procedure/surgery

Sponsors

Instituto Prevent Senior
Lead Sponsor
Instituto Prevent Senior
Collaborator

Eligibility

Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Healthy volunteers; chronic pain; plantar fasciitis; age over 18 years

Exclusion criteria

Exclusion criteria: Neuropathy; skin lesions; degenerative lesions; previous allergy to sodium hyaluronate; allergies to avian proteins; collagen disorders; rheumatoid arthritis; seronegative arthritis.

Design outcomes

Primary

MeasureTime frame
It is expected to find an improvement in pain in both arms of the study, verified through the application of validated pain scores, from the observation of a variation of at least 10% in the pre and post-intervention measurements.

Secondary

MeasureTime frame
It is expected to find an improvement in function in both arms of the study, verified through the application of validated function scores, from the observation of a variation of at least 10% in the pre and post-intervention measurements.

Countries

Brazil

Contacts

Public ContactGabriel Ferreira

Instituto Prevent Senior

gabriel.ferraz38@yahoo.com.br+55-11-35547084

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 15, 2026